NCT00397982 · Interventional trial
Temsirolimus and Bevacizumab in Treating Patients With Stage III or Stage IV Malignant Melanoma
Overall registry status Completed
Phase 2
Conditions Recurrent Melanoma, Stage IIIB Skin Melanoma, Stage IIIC Skin Melanoma, Stage IV Skin Melanoma
Delaware Valley sites
- Fox Chase Cancer Center · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory